MoneyWorks4Me

The sales surged to Rs. 1223.08 millions, up 34.00% for the September 2021 quarter as against Rs. 912.78 millions during the corresponding quarter previous year.Net profit stood at Rs. 174.71  millions  compared to Rs. 152.23 millions in the corresponding previous quarter,high by 14.77%.Operating Profit saw a handsome growth to 275.34 millions from 229.56 millions in the quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202109 202009 % Var
Sales 1223.08 912.78 34.00 1223.08 912.78 34.00 1223.08 912.78 34.00
Other Income 1.63 10.91 -85.06 1.63 10.91 -85.06 1.63 10.91 -85.06
PBIDT 275.34 229.56 19.94 275.34 229.56 19.94 275.34 229.56 19.94
Interest 26.92 14.03 91.87 26.92 14.03 91.87 26.92 14.03 91.87
PBDT 248.42 215.53 15.26 248.42 215.53 15.26 248.42 215.53 15.26
Depreciation 23.18 11.31 104.95 23.18 11.31 104.95 23.18 11.31 104.95
PBT 225.24 204.22 10.29 225.24 204.22 10.29 225.24 204.22 10.29
TAX 50.53 51.99 -2.81 50.53 51.99 -2.81 50.53 51.99 -2.81
Deferred Tax 7.06 1.55 355.48 7.06 1.55 355.48 7.06 1.55 355.48
PAT 174.71 152.23 14.77 174.71 152.23 14.77 174.71 152.23 14.77
Equity 364.37 105.00 247.02 364.37 105.00 247.02 364.37 105.00 247.02
PBIDTM(%) 22.51 25.15 -10.49 22.51 25.15 -10.49 22.51 25.15 -10.49
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..